Leo Donato Giuseppe, Russell Aisling, Bridgens Anna, Perry Daniel C, Eastwood Deborah M, Gelfer Yael
Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Science, University of Liverpool, Liverpool, UK.
St George's Healthcare NHS Trust, London, UK.
Bone Jt Open. 2021 Apr;2(4):255-260. doi: 10.1302/2633-1462.24.BJO-2020-0202.R1.
This study aims to define a set of core outcomes (COS) to allow consistent reporting in order to compare results and assist in treatment decisions for idiopathic clubfoot.
A list of outcomes will be obtained in a three-stage process from the literature and from key stakeholders (patients, parents, surgeons, and healthcare professionals). Important outcomes for patients and parents will be collected from a group of children with idiopathic clubfoot and their parents through questionnaires and interviews. The outcomes identified during this process will be combined with the list of outcomes previously obtained from a systematic review, with each outcome assigned to one of the five core areas defined by the Outcome Measures Recommended for use in Randomized Clinical Trials (OMERACT). This stage will be followed by a two round Delphi survey aimed at key stakeholders in the management of idiopathic clubfoot. The final outcomes list obtained will then be discussed in a consensus meeting of representative key stakeholders.
The inconsistency in outcomes reporting in studies investigating idiopathic clubfoot has made it difficult to define the success rate of treatments and to compare findings between studies. The development of a COS seeks to define a minimum standard set of outcomes to collect in all future clinical trials for this condition, to facilitate comparisons between studies and to aid decisions in treatment. Cite this article: 2021;2(4):255-260.
本研究旨在确定一组核心结局指标(COS),以便进行一致的报告,从而比较结果并协助做出特发性马蹄内翻足的治疗决策。
将通过三个阶段的过程从文献和关键利益相关者(患者、家长、外科医生和医疗保健专业人员)那里获取结局指标列表。将通过问卷调查和访谈从一组患有特发性马蹄内翻足的儿童及其家长中收集对患者和家长而言重要的结局指标。在此过程中确定的结局指标将与先前通过系统评价获得的结局指标列表相结合,每个结局指标将被分配到《推荐用于随机临床试验的结局测量指标》(OMERACT)定义的五个核心领域之一。此阶段之后将针对特发性马蹄内翻足管理中的关键利益相关者进行两轮德尔菲调查。然后,将在有代表性的关键利益相关者的共识会议上讨论最终获得的结局指标列表。
在研究特发性马蹄内翻足的研究中,结局指标报告的不一致使得难以确定治疗的成功率并比较不同研究的结果。制定核心结局指标旨在定义在今后针对这种疾病的所有临床试验中要收集的一组最低标准的结局指标,以促进不同研究之间的比较并辅助治疗决策。引用本文:2021;2(4):255 - 260。